Agoracom Blog Home

Posts Tagged ‘datametrex’

« Older Entries
Newer Entries »

Datametrex $DM.ca Reports Government Clearance To Fulfill Its First #COVID19 Test Kit Order

Posted by AGORACOM-JC at 2:17 PM on Wednesday, June 3rd, 2020
  • Announced that its purchaser has received Government clearance to fulfill the purchase order for COVID-19 test kits for its client, a mining company operational in Mali, West Africa
  • Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples
  • The total gross sales amount is approximately $500,000 CDN, excluding shipping

TORONTO, June 03, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that its purchaser has received Government clearance to fulfill the purchase order (the “PO”) for COVID-19 test kits for its client, a mining company operational in Mali, West Africa.

Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour.

The total gross sales amount is approximately $500,000 CDN, excluding shipping. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits.

With the Government clearance, the Company is in process of organizing shipping. All of the items will be shipped directly from manufacturers to the purchaser at their operating site in West Africa. Security clearance backlogs continue to streamline as Governments align with the World Health Organization’s remarks on the importance of testing. Governments have urged mining companies to implement testing and screening their workforce to properly fight the virus in order to avoid further closures.

“The opportunity to use advanced COVID-19 testing kits from our partners in Korea to support the diagnostic potential for populations provides an exciting opportunity for countries during this pandemic and the African continent,” says Marshall Gunter, CEO of the Company. “Datametrex is honored to be assisting in the health and welfare of mine employees and local contractors.”

According to Africa Centres for Disease Control and Prevention (the “Africa CDC”), there are over 150,000 cases of COVID-19 throughout Africa and with this, Researchers at the African Center of Excellence for Genomics of Infectious Diseases (the “ACEGID”) and other research and public health partners, have announced to implement a Sentinel Project (the “Sentinel”) serveilance protocol for an early warning system in Africa. The Sentinel is the first of eight new projects selected, and it has three pillars: (1) detect, (2) connect and (3) empower. And in the third pillar, the project will empower public health experts by training thousands of healthcare professionals to use the Sentinel tools and deploy the diagnostic technologies for population-level COVID-19 testing, building on previous experiences of ACEGID and the Broad Institute in training over 900 individuals from around the world.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Reports Government Clearance To Fulfill Its First #COVID19 Test Kit Order

#AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:12 PM on Tuesday, June 2nd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI tools could improve fake news detection by analyzing users’ interactions and comments

  • According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral
  • Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity

By: Kyle Wiggers

In a paper published on the preprint server Arxiv.org, researchers affiliated with Microsoft and Arizona State University propose an approach to detecting fake news that leverages a technique called weak social supervision. They say that by enabling the training of fake news-detecting AI even in scenarios where labeled examples aren’t available, weak social supervision opens the door to exploring how aspects of user interactions indicate that news might be misleading.

According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral. Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity.

Building on a study published in April, the coauthors of this latest work suggest that weak supervision — where noisy or imprecise sources provide data labeling signals — could improve fake news detection accuracy without requiring fine-tuning. To this end, they built a framework dubbed Tri-relationship for Fake News (TiFN) that models social media users and their connections as an “interaction network” to detect fake news.

Interaction networks describe the relationships between entities like publishers, news stories, and users. Given an interaction network, TiFN aims to embed different types of entities, based on the observation that people tend to interact with like-minded friends. In making its predictions, the framework also accounts for the fact that connected users are more likely to share similar interests in news pieces, that publishers with a high degree of political bias are more likely to publish fake news, and that users with low credibility are more likely to spread fake news.VB Transform 2020 Online – July 15-17. Join leading AI executives: Register for the free livestream.

To test whether TiFN’s weak social supervision could help to detect fake news effectively, the team validated it against a Politifact data set containing 120 true news pieces and 120 verifiably fake pieces shared among 23,865 users. Versus baseline detectors that consider only news content and some social interactions, the researchers report that TiFN achieved between 75% to 87% accuracy, even with a limited amount of weak social supervision (within 12 hours after the news was published).

In another experiment — involving a separate custom framework called Defend — the researchers sought to use news sentences and user comments explaining why a piece of news is fake as a weak supervision signal. Tested on a second Politifact data set consisting of 145 true news and 270 fake news pieces with 89,999 comments from 68,523 users on Twitter, they say Defend achieved 90% accuracy.

“[W]ith the help of weak social supervision from publisher-bias and user-credibility, the detection performance is better than those without utilizing weak social supervision. We [also] observe that when we eliminate [the] news content component, user comment component, or the co-attention for news contents and user comments, the performances are reduced. [This] indicates capturing the semantic relations between the weak social supervision from user comments and news contents is important,” wrote the researchers. “[W]e can see [that] within a certain range more weak social supervision leads to a larger performance increase, which shows the benefit of using weak social supervision.”

Source: https://venturebeat.com/2020/06/01/ai-tools-could-improve-fake-news-detection-by-analyzing-users-interactions-and-comments/

Tags: , , , ,
Posted in Datametrex AI Limited | Comments Off on #AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Posted by AGORACOM-JC at 9:16 AM on Thursday, May 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.

Then, when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.

But the real credibility payoff comes when a global mining giant, with 4,000 employees across the world, knocks on your door to buy 10,000 kits for the purposes of protecting both their employees and their families in order to get operations re-started.

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup. But Datametrex AI (DM: TSXV) is neither. Rather, it is a great Canadian small cap technology company who is giving small cap investors an opportunity to participate in the emerging world of Artificial Intelligence, as well as, the brand new world of COVID-19 testing.

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government and global conglomerates to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses how the Company was able to secure its first order of 10,000 COVID-19 test kits for $500,000.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on INTERVIEW: Datametrex $DM.ca Sells 10,000 COVID-19 Test Kits In $500,000 Deal With Global Mining Company

Datametrex $DM.ca Adds Pharmacologist Alex MacGregor to the Medical Advisory Board

Posted by AGORACOM-JC at 10:04 AM on Tuesday, May 19th, 2020
  • President and Dean of the Toronto Institute of Pharmaceutical Technology and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., a, has consented to join the Company’s Medical Advisory Board.
  • Company is also in discussion with Transpharm Canada Inc. the parent company of Toronto Institute of Pharmaceutical Technology to provide lab testing services using there fully compliant Health Canada licensed Good Manufacturing Practice manufacturing and testing facility located in Toronto, ON, Canada

TORONTO, May 19, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPT”) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., a, has consented to join the Company’s Medical Advisory Board.

The Company is also in discussion with Transpharm Canada Inc. (“TCI”), the parent company of Toronto Institute of Pharmaceutical Technology to provide lab testing services using their fully compliant Health Canada licensed Good Manufacturing Practice (“GMP”) manufacturing and testing facility located in Toronto, ON, Canada. Having a mass testing partner will be a key growth driver for the Company and will be working to solidify an agreement on this prospective joint project.

Datametrex is extremely pleased to have an medical patent holder and pharmacologist with the experience and abilities of Dr. MacGregor join its Medical Advisory Board,” said Marshall Gunter, CEO of Datametrex. “Alexander will be an excellent source of advice as the Company advances a key part of covid-19 with lab capacity and his and his teams pharmacology expertise. We welcome Dr. MacGregor and look forward to his valued contribution as the newest member of our team.”

Dr. Alexander MacGregor stated, “I am very pleased to join the Company’s medical advisory board. With this unprecedented pandemic terribly affecting people worldwide and has temporarily changed the way the world operates, I am pleased to be assisting Datametrex with my teams expertise in lab testing on the front lines and assisting developing a plan to meet the enormous demand coming in COVID-19 testing and working on lowering the curve during this outbreak.”

About Dr. Alexander MacGregor

A leader in the fields of pharmaceutical technology, research, and training, Dr. MacGregor has served as the President and Dean of Faculty of the Toronto Institute of Pharmaceutical Technology (TIPT®) since 1992.

The holder of several scientific patents, Dr. MacGregor currently oversees clinical testing trials of several drugs in the areas of cholesterol lowering, diabetes, anti-infective, post-operative pain, epilepsy, and congestive heart failure.

Dr. MacGregor obtained his Ph.D. in clinical pharmacology from the University of London Postgraduate Medical School after earning B.Sc. (Honors) in Medical Biochemistry from the Cardif University in Wales. In 1997, Dr. MacGregor completed a Master-Class Certification Program in Pharmaceutical Technology from the European Continuing Education College at the University of Liverpool.

In 1990, Dr. MacGregor moved to Canada to assume the role of managing director of Transpharm International UK Ltd., a scientific enterprise specializing in clinical testing and pharmaceutical drug licensing. Throughout the decade, Dr. MacGregor functioned as a consultant to major pharmaceutical industries in Europe, Asia, and North America.

Dr. MacGregor currently divides his time between TIPT, one of North America’s leading postgraduate pharmaceutical and research organizations, and ORx Pharmaceutical Corporation, where he serves as chairman and Chief Scientific Officer. In the latter capacity, Dr. MacGregor designs and develops clinical delivery methods of therapeutic compounds.

At TIPT, Dr. MacGregor runs a highly regarded training program in pharmaceutical sciences and technology. More than 7,500 successful TIPT graduates operate in all areas of the pharmaceutical industry including quality control analysis, regulatory affairs administration, clinical quality control, and clinical data review.

An active humanitarian within the African-Canadian community, Dr. MacGregor supports such organizations as the Canadian Association of Black Lawyers (CABL) and the Association of Black Law Enforcers (ABLE). Dr. MacGregor also donates generously to charities such as the United Way and the Nelson Mandela Children’s fund.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Adds Pharmacologist Alex MacGregor to the Medical Advisory Board

Datametrex Announces Sale of COVID-19 Test Kit to Canadian Mining Company

Posted by AGORACOM-JC at 10:27 AM on Friday, May 15th, 2020
  • Received a purchase order for COVID-19 test kits from a Canadian based mining company with over 4,000 employees in multiple jurisdictions outside of Canada
  • Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of COVID-19 Detection Kits, comprising of 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples
  • Total gross sales amount is approximately $500,000 CDN, excluding shipping

TORONTO, May 15, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce it has received a purchase order for (the “PO”) COVID-19 test kits from a Canadian based mining company with over 4,000 employees in multiple jurisdictions outside of Canada.

Under the terms of the PO, Datametrex will sell to the purchaser an initial 10,000 units of COVID-19 Detection Kits, comprising of 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The total gross sales amount is approximately $500,000 CDN, excluding shipping. Datametrex anticipates that it will have little or no upfront costs associated with the sale of these test kits. The Company has secured all testing kits, swabs, tubes and the PCR machine from the manufacturer required to fulfill the order. All of the items will be shipped directly from manufacturers to the purchaser at their operating site in Africa.

“Datametrex is honoured to be assisting this Canadian company to protect and safeguard the health and welfare of their employees, local contractors, and the local population. We are proud to be able to help Canadians and companies to reopen businesses around the world and to help people return to work safely. We sincerely wish them and all Canadian companies the best during this pandemic,” says Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex Announces Sale of COVID-19 Test Kit to Canadian Mining Company

How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:46 PM on Tuesday, May 12th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

How Facebook is using AI to combat COVID-19 misinformation and detect ‘hateful memes’

By Nick Statt

Facebook on Monday released a new report detailing how it uses a combination of artificial intelligence and human fact-checkers and moderators to enforce its community standards. The report — called the Community Standards Enforcement Report, which usually encompasses data and findings from the prior three to six months — has a large focus on AI this time around.

That’s because Facebook is relying more on the technology to help moderate its platform during the COVID-19 pandemic, which is preventing the company from using its usual third-party moderator firms because those firms’ employees are not allowed to access sensitive Facebook data from home computers.

That said, Facebook says the data it’s compiled so far doesn’t contain any larger trends in its enforcement or in offending behavior on its platform because the pandemic hit so late in its reporting period. “This report includes data only through March 2020 so it does not reflect the full impact of the changes we made during the pandemic,” writes Guy Rosen, the company’s vice president of integrity, in a blog post. “We anticipate we’ll see the impact of those changes in our next report, and possibly beyond, and we will be transparent about them.’

Given the state of the world, Facebook’s report does contain new information about how the company is specifically combating coronavirus-related misinformation and other forms of platform abuse, like price gouging on Facebook Marketplace, using its AI tools. Facebook put warning labels on 50 million coronavirus-related posts last month

“During the month of April, we put warning labels on about 50 million posts related to COVID-19 on Facebook, based on around 7,500 articles by our independent fact-checking partners,” the company said in a separate blog post, penned by a group of its research scientists and software engineers, about its ongoing COVID-19 misinformation efforts published today. “Since March 1st, we’ve removed more than 2.5 million pieces of content for the sale of masks, hand sanitizers, surface disinfecting wipes and COVID-19 test kits. But these are difficult challenges, and our tools are far from perfect. Furthermore, the adversarial nature of these challenges means the work will never be done.”

Facebook says its labels are working: 95 percent of the time, someone who is warned that a piece of content contains misinformation will decide not to view it anyway. But producing those labels across its enormous platform is proving to be a challenge. For one, Facebook is discovering that a fair amount of misinformation as well as hate speech is now showing up in images and videos, not just text or article links.

“We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos,” the company says in a separate hate speech-specific blog post about its recent moderation findings and research. “As with other content, hate speech also can be multimodal: A meme might use text and image together to attack a particular group of people, for example.”

This is a tougher challenge for AI to tackle, the company admits. Not only do AI-trained models have a harder time parsing a meme image or a video due to complexities like wordplay and language differences, but that software must also then be trained to find duplicates or only marginally modified versions of that content as it spreads across Facebook. But this is precisely what Facebook says it’s achieved with what it calls SimSearchNet, a multiyear effort across many divisions within the company to train an AI model how to recognize both copies of the original image and those that are near-duplicates and have perhaps one word in the line of text changed. “We have found that a substantial percentage of hate speech on Facebook globally occurs in photos or videos.”

“Once independent fact-checkers have determined that an image contains misleading or false claims about coronavirus, SimSearchNet, as part of our end-to-end image indexing and matching system, is able to recognize near-duplicate matches so we can apply warning labels,” the company says. “This system runs on every image uploaded to Instagram and Facebook and checks against task-specific human-curated databases. This accounts for billions of images being checked per day, including against databases set up to detect COVID-19 misinformation.”

Facebook uses the example of a misleading image modeled after a broadcast news graphic with a line of overlaid text reading, “COVID-19 is found in toilet paper.” The image is from a known peddler of fake news called Now8News, and the graphic has since been debunked by Snopes and other fact-checking organizations. But Facebook says it had to train its AI to differentiate between the original image and a modified one that says, “COVID-19 isn’t found in toilet paper.”

The goal is to help reduce the spread of duplicate images while also not inadvertently labeling genuine posts or those that don’t meet the bar for misinformation. This is a big problem on Facebook where many politically motivated pages and organizations or those that simply feed off partisan outrage will take photographs, screenshots, and other images and alter them to change their meaning. An AI model that knows the difference and can label one as misinformation and the other as genuine is a meaningful step forward, especially when it can then do the same to any duplicate or near-duplicate content in the future without roping in non-offending images in the process.

Source: https://www.theverge.com/2020/5/12/21254960/facebook-ai-moderation-covid-19-coronavirus-hateful-memes-hate-speech

Tags: , , , , ,
Posted in Datametrex AI Limited | Comments Off on How #Facebook is using #AI to combat #COVID19 misinformation and detect ‘hateful memes’ – SPONSOR: Datametrex AI Limited $DM.ca

Datametrex $DM.ca Obtains Rights to Sell Health Canada Approved #COVID19 Test Kit

Posted by AGORACOM-JC at 9:42 AM on Monday, May 11th, 2020
  • Secured non-exclusive rights to COVID-19 test kits with Health Canada approval,
  • Kingdom of Saudi Arabia, Saudi Food & Drug Authority approval, and
  • CE marking certification for European Economic Area countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit.
  • latest, and fourth kit to be added by Datametrex to distribute is the 1copy™ COVID-19 qPCR Multi Kit
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

TORONTO, May 11, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to COVID-19 test kits with Health Canada (“HC”) approval, Kingdom of Saudi Arabia, Saudi Food & Drug Authority (“SFDA”) approval, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit. 

The latest, and fourth kit to be added by Datametrex to distribute is the 1copy™ COVID-19 qPCR Multi Kit (“qPCR kit”), which is Health Canada approved with Authorization Reference Number 312777, Device ID 1020660 and Model No. M22MD100. It is a nucleic test kit providing results in less than two hours that verifies the RdRp gene for SARS-CoV-2 with real-time qPCR kit via a nasopharyngeal swab and oropharyngeal swab, specifically targeting the E gene sequences of COVID-19. The kits are made by 1drop Inc. (“1drop”) in South Korea, and are immediately ready for sales orders in Canada.

1drop is located in South Korea and is a medical technology spin-off from Samsung Electronic’s C-Lab program. The C-Lab is an internal incubation program within Samsung that first started in 2012 to help inspire a more creative company culture. 1drop already has more than five products approved in Europe in the past 18 month under the CE marking certification. “CBC News reported that Canada lost almost two million jobs during the month of April as the impact of COVID-19 according to Stats Canada’s release on May 8, 2020. The team has been working around the clock to identify and source high quality test kits from South Korea for Canada. We are thrilled to have secured the rights to sell kits from 1drop, Health Canada approved manufacturer. We will be able to start filling orders immediately and are looking forward to help flatten the curve and get Canadians back to work safely,” says Marshall Gunter, CEO of the Company.

The Company’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 tests, there is volatility in the supply chain, and available supply may fluctuate on a daily basis.

Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits. Assuming these test kits are purchased by the Canadian Government, the manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing, or distribution process.

The Company did not pay consideration to the manufacturer to obtain sales rights.

The Company granted 16,500,000 incentive stock options to its directors, officers, employees and consultants in accordance with the Company’s Stock Option Plan. These stock options have an exercise price of $0.17 and expire on June 30, 2022.  All options will be subject to a vesting schedule, with 25% immediately vesting and 25% vesting on the three, six and nine month anniversaries of the grant date.

About CE Marking

CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards. This makes the CE marking recognizable worldwide even to people who are not familiar with the European Economic Area (the 27 member states of the EU, the 4 members of European Free Trade Association (“EFTA”), plus Turkey and United Kingdom). CE marking also supports fair competition by holding all companies accountable to the same rules. For more information please consult the European Commission website at: CE marking

About Kingdom of Saudi Arabia, Saudi Food & Drug Authority (“SFDA”)

The Saudi Food & Drug Authority (SFDA) is the government agency that regulates drugs and medical devices in Saudi Arabia. It is also in charge of biological and chemical substances, as well as electronic products. The agency was established under the Council of Ministers and functions under the Council of Ministers as an independent body that reports to the President of Council of Ministers.

SFDA is in charge of overseeing the safety, security and effectiveness of medical devices, ensuring their accuracy, and controlling and supervising manufacturing facilities, as well as overseeing the importation and registration of these products.

A list of regulations can be found here on SFDA website.

About 1drop Inc.

1drop is located in Jungwon-gu, South Korea, and was incorporated in 2017 following a technology spin-off from Samsung Electronic’s C-Lab program. Samsung Electronic’s C-Lab, located in South Korea is an internal incubation program that first started in 2012 to help inspire a more creative company culture. 1drop already had more than five products approved in Europe in the past 18 month under CE marking is a certification.

For more information please consult the website at: 1drop

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Obtains Rights to Sell Health Canada Approved #COVID19 Test Kit

#AI can distinguish between bots and humans based on #Twitter activity – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 10:08 AM on Thursday, May 7th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI can distinguish between bots and humans based on Twitter activity

  • Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter
  • Researchers found that human users replied between four and five times more often to other tweets than bots did
  • Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use

By Donna Lu

Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter.

Emilio Ferrara at the University of Southern California and his colleagues have trained an AI to detect bots on Twitter based on differences in patterns of activity between real and fake accounts.

The team analysed two separate data sets of Twitter users, which had been classified either manually or by a pre-existing algorithm as either bot or human.

The manually verified data set consisted of 8.4 million tweets from 3500 human accounts, and 3.4 million tweets from 5000 bots.

The researchers found that human users replied between four and five times more often to other tweets than bots did. Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use.

The length of tweets by human users also decreased as sessions progressed. “The amount of information that is exchanged diminishes,” says Ferrara. He believes that the change may result from a cognitive depletion over time, in which people become less likely to expend mental effort composing original content.

Bots, on the other hand, show no changes in their interactivity or the length of information they tweet over time.

Read more: https://www.newscientist.com/article/2241327-ai-can-distinguish-between-bots-and-humans-based-on-twitter-activity/#ixzz6LlMIFlYe

Tags: , , , ,
Posted in Datametrex AI Limited | Comments Off on #AI can distinguish between bots and humans based on #Twitter activity – SPONSOR: Datametrex AI Limited $DM.ca

Datametrex $DM.ca Obtains Rights to Sell #COVID19 Tests From Two Additional South Korean Manufacturers

Posted by AGORACOM-JC at 7:32 AM on Wednesday, May 6th, 2020
  • Secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration
  • Approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices for the United States, and CE marking certification (for European Economic Area countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit

TORONTO, May 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration (“FDA”) approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”) for the United States, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit.

According to each of the manufacturers, these test kits made are both Nucleic Acid based, which Health Canada is prioritizing the review of. Each of the manufacturers’ test kits have been submitted to Health Canada approval on a fast track basis and, until such approval is granted, these tests may not be sold or used in Canada. The Company is currently working closely with Health Canada to have the approval of the test kits fast tracked. An Interim Order Request for Health Canada has been submitted for 300,000 kits immediately and an additional 100,000 weekly thereafter.

One of the test kits, manufactured by Seasun Biomaterials (“Seasun”) Inc. of South Korea, was authorized on April 27, 2020 by the FDA in the United States for Emergency Use under the EUA by authorized laboratories and has also been approved for use in the EEA with CE marking certification. With regard to the FDA authorization: (1) this test has not been FDA cleared or approved; (2) this test has been authorized by the FDA only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and (3) this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Seasun claims that the average number of specimens that can be tested in a 12 hour period with their U-TOP COVID-19 Real-Time Detection Kit is 3,400. Seasun advises this is the equivalent of approximately 283 tests per hour, and the kit uses dual-labeled peptide nucleic acid probes to detect two distinct regions in ORF1ab and one region in N gene of the SARS-CoV-2 genome in oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, and sputum. The test runs on any authorized RT-PCR instrument and can be performed by any lab CLIA-certified to perform high-complexity tests.

Seasun is an in vitro diagnostic company that develops molecular diagnostic platforms of infection diseases, cancer as well as genetic and epigenetic disorders. Seasun develops and commercializes innovative real-time PCR-based diagnostic platforms through the development of its proprietary technologies to provide more advanced molecular diagnostic services. Seasun’s test kits will be distributed by its third party distributor, which Datametrex has agreements in place with for distribution globally. The other manufacturer that Datametrex has obtained sales rights from has requested not to be named publicly at this time.

The Company announced on April 21, 2020 the appointments of Dr. Joseph Curtis and Dr. Lisa Palleson-Stallan to the advisory board in anticipation of securing US FDA EUA approval on the test kits. Selling into the US market requires infrastructure and a qualified contact person that can assist not only in identifying opportunities to sell the test kits but also with the compliance requirements. The Company is continuing to work with Health Canada with respect to the application for approval of previously announced iONEBIO Inc. COVID-19 test kits.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA under EUA approved test kits allow us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Marshall Gunter, CEO of the Company.

The Company’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, the manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

The Company did not pay consideration to either of the manufacturers to obtain sales rights. Seasun’s application to have its test approved by Health Canada were submitted directly by Seasun, while Datametrex submitted an application for approval with respect to the other manufacturer’s tests.

About CE Marking

CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards. This makes the CE marking recognizable worldwide even to people who are not familiar with the European Economic Area (the 27 member states of the EU, the 4 members of European Free Trade Association (“EFTA”), plus Turkey and United Kingdom). CE marking also supports fair competition by holding all companies accountable to the same rules. For more information please consult the European Commission website at: CE marking.

About Food and Drug Administration EUA

On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens – Advisor
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Obtains Rights to Sell #COVID19 Tests From Two Additional South Korean Manufacturers

#Google acts tough on ‘bad ads’; blocked nearly 1 million advertisers in 2019 – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 2:30 PM on Tuesday, May 5th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Google acts tough on ‘bad ads’; blocked nearly 1 million advertisers in 2019

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior to protect users from ads looking to take advantage of the crisis.

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior.

By: FE Online

  • Google on Monday said it disabled and eliminated 2.7 billion ‘bad ads’-more than 5,000 poor ads every minute-in 2019, and banned nearly a million advertisers responsible for policy breaches as part of its efforts to protect consumers from deceptive advertising.

The tech giant also noticed that fake advertisements for in-demand items such as face masks had a dramatic increase in the COVID-19 pandemic that claimed lakhs of life globally.

“Preserving the integrity of the ads on our platforms, as we’re doing during the COVID-19 outbreak, is a continuation of the work we do every day to minimise content that violates our policies and stop malicious actors. We have thousands of people working across our teams to make sure we’re protecting our users and enabling a safe ecosystem for advertisers and publishers…” Google has informed me in a blogpost.

The post, written by Google Vice President of Product Management Advertising Protection and Safety Scott Spencer, noted that in 2019, 2.7 billion bad advertising were blocked and taken out.

“We also suspended nearly 1 million advertiser accounts for policy violations. On the publisher side, we terminated over 1.2 million accounts and removed ads from over 21 million web pages that are part of our publisher network for violating our policies,” the blog said.

It added that terminating accounts-not just removing an individual ad or page-is a particularly effective enforcement tool that Google uses if advertisers or publishers commit egregious policy breaches or have a history of policy breaches.

Google said since the beginning of the COVID-19 outbreak, it has been closely monitoring advertiser behavior to protect users from ads looking to take advantage of the crisis. Google said it has been closely tracking advertiser activity since the start of the COVID-19 outbreak to protect consumers from advertisers that are trying to take advantage of the crisis.

Google noted that there is a dedicated COVID-19 task force operating round the clock that has developed new detection technologies and has also improved existing compliance tools to avoid bad actors.

Source: https://www.financialexpress.com/industry/technology/google-acts-tough-on-bad-ads-blocked-nearly-1-million-advertisers-in-2019/1948767/

Tags: , , , ,
Posted in Datametrex AI Limited | Comments Off on #Google acts tough on ‘bad ads’; blocked nearly 1 million advertisers in 2019 – SPONSOR: Datametrex AI Limited $DM.ca

« Older Entries
Newer Entries »